Harriet Mears

Affiliated Researcher

Displaying 1 - 17 of 17
Last updated : 11 July 2026 02:24

Real-time estimation of immunological responses against emerging SARS-CoV-2 variants in the UK: a mathematical modelling study

Authors (44)
  • Timothy W Russell
  • Hermaleigh Townsley
  • Joel Hellewell
  • Joshua Gahir
  • Marianne Shawe-Taylor
  • David Greenwood
  • [...]
  • Mary Wu
  • David LV Bauer
  • Edward Carr
  • Emma Wall
  • Adam J Kucharski
The Lancet Infectious Diseases
Published
Crick labs/ facilities
Full details

COVID-19 in non-hospitalised adults caused by either SARS-CoV-2 sub-variants Omicron BA.1, BA.2, BA.4/5 or Delta associates with similar illness duration, symptom severity and viral kinetics, irrespective of vaccination history

Authors (37)
PLOS ONE
Published
Crick labs/ facilities
Full details

Combined analyses of within-host SARS-CoV-2 viral kinetics and information on past exposures to the virus in a human cohort identifies intrinsic differences of Omicron and Delta variants

Authors (26)
PLOS Biology
Published
Crick labs/ facilities
Full details

SARS-CoV-2 mucosal neutralising immunity after vaccination

Authors (38)
The Lancet Infectious Diseases
Published
Crick labs/ facilities
Full details

Neutralising immunity to omicron sublineages BQ.1.1, XBB, and XBB.1.5 in healthy adults is boosted by bivalent BA.1-containing mRNA vaccination and previous Omicron infection

Authors (36)
The Lancet Infectious Diseases
Published
Crick labs/ facilities
Full details

Dichotomy of neutralizing antibody, B cell and T cell responses to SARS-CoV-2 vaccination and protection in healthy adults

Preprint
Authors (39)
bioRxiv
Published
Crick labs/ facilities
Full details

Three-dose vaccination elicits neutralising antibodies against omicron

Authors (26)
The Lancet
Published
Crick labs/ facilities
Full details